Siemens Healthineers (NYSE:SI) and Hill-Rom (NYSE:HRC) inked a co-marketing agreement to provide an array of point-of-care diagnostic instruments for diabetes to primary healthcare providers in the U.S.
The offering is slated to include Siemens’ DCA Vantage Analyzer for HbA1c testing, the Clinitek Status+ Urine Chemistry Analyzer for kidney testing and Hill-Rom’s Welch Allyn RetinaVue Network and imaging tech for teleretinal exams.
Get the full story at our sister site, Drug Delivery Business News.
The post Siemens Healthineers and Hill-Rom team up to provide diabetes tools to primary care providers appeared first on MassDevice.
from MassDevice https://ift.tt/2HUZ5zC
Cap comentari:
Publica un comentari a l'entrada